Health
Tocilizumab, Rheumatoid Arthritis Medication, Found to Reduce Severe COVID-19 Deaths – Science Times
Clinical trials in 12 public and private hospitals in India headed by the University of Bristol and Medanta Institute of Education and Research add evidence to…
India, one of the most ethnically diverse countries, conducted the first randomized trials on the use of rheumatoid arthritis medication, Tocilizumab, to reduce death risks in severe COVID-19 cases.
Headed by researchers from the University of Bristol and Medanta Institute of Education and Research, they explained that data gathered from clinical trials add to existing evidence that supports the use of Tocilizumab, an anti-inflammatory drug, in critically ill patients.
Science Behind Tocilizumab…
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General17 hours agoAustralian share market set to dive as threat of US recession grows